The light therapy market is projected to expand from US$ 930.69 million in 2022 to US$ 1,434.25 million by 2030, with an anticipated compound annual growth rate (CAGR) of 5.6% during the period from 2022 to 2030.

Light therapy, often referred to as phototherapy, involves the therapeutic application of specific light wavelengths to treat various conditions, including skin disorders, mood-related issues, and sleep disturbances. This non-invasive treatment method utilizes the distinct characteristics of light to provoke biological reactions in the body, primarily targeting the skin or retina, while also affecting circadian rhythms and mood-regulating systems. Different forms of light therapy exist, such as blue light therapy for acne treatment, red light therapy for skin rejuvenation, and bright light therapy aimed at alleviating seasonal affective disorder (SAD).

The growth of the light therapy market is significantly influenced by rapid technological advancements.

Technological innovations in light therapy have been crucial in driving the market's expansion and dynamism. These advancements have resulted in sophisticated light delivery systems that allow for precise control over light wavelengths, intensity, and dosimetry. The integration of smart technologies, including wearable devices and connected light therapy platforms, has improved accessibility and personalized treatment options, thereby enhancing adherence to prescribed light therapy regimens. Additionally, ongoing research in photobiomodulation has broadened the therapeutic applications of light therapies, leading to a diversification of uses and an expansion of the market. The introduction of innovative devices designed for regulating circadian rhythms and the development of home-use light therapy solutions have made these therapies more accessible and user-friendly. Consequently, technological progress continues to redefine the light therapy landscape, fostering innovation, enhancing accessibility, and diversifying applications across healthcare, wellness, and consumer sectors, which in turn propels market growth and broadens its adoption to meet the evolving needs of various end-users.

The light therapy market is categorized based on type, light type, application, and end user. In terms of type, the market is divided into benchtop and portable devices. The light therapy market is further segmented by light type into red, blue, and white light. Applications of light therapy include mental health disorders, skin disorders, neonatal care, and other uses. The end-user classification includes hospitals, specialty clinics, homecare, and additional categories. Geographically, the light therapy market is segmented into North America (including the US, Canada, and Mexico), Europe (covering the UK, Germany, France, Italy, Spain, and the rest of Europe), Asia Pacific (including China, Japan, India, South Korea, Australia, and the rest of Asia Pacific), the Middle East & Africa (comprising the UAE, Saudi Arabia, South Africa, and the rest of the Middle East & Africa), and South & Central America (including Brazil, Argentina, and the rest of South & Central America).

In terms of geography, North America stands out as the leading contributor to the growth of the light therapy market, primarily due to the rising prevalence of conditions such as psoriasis and symptoms associated with SAD or winter blues. In 2022, North America dominated the global light therapy market. Light treatment, conducted under medical supervision, involves exposing the skin to artificial UV light sources, utilizing either UVB or UVA light, or a combination of both, to alleviate symptoms, reduce inflammation, and control skin cell proliferation. According to the Canadian Dermatology Association, approximately one million Canadians are affected by psoriasis, which drives the demand for light therapy devices.

The Asia Pacific region is anticipated to experience the highest CAGR from 2022 to 2030, attributed to increased investments in telemedicine and a growing awareness of the benefits of light therapy. The market growth is also supported by the rising adoption of light therapy devices in clinics, hospitals, and home care settings. The increasing incidence of sleep disorders and the expanding application of light therapy devices for treating skin conditions such as eczema, psoriasis, and acne are expected to further stimulate market growth in the coming years.

Key primary and secondary sources, including the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA), have been referenced in the preparation of the light therapy market report.